Risk assessment of COVID-19 epidemic resurgence in relation to SARS-CoV-2 variants and vaccination passes

Abstract Background The introduction of COVID-19 vaccination passes (VPs) by many countries coincided with the Delta variant fast becoming dominant across Europe. A thorough assessment of their impact on epidemic dynamics is still lacking.Methods Here, we propose the VAP-SIRS model that considers possibly lower restrictions for the VP holders than for the rest of the population, imperfect vaccination effectiveness against infection, rates of (re-)vaccination and waning immunity, fraction of never-vaccinated, and the increased transmissibility of the Delta variant.Results Some predicted epidemic scenarios for realistic parameter values yield new COVID-19 infection waves within two years, and high daily case numbers in the endemic state, even without introducing VPs and granting more freedom to their holders. Still, suitable adaptive policies can avoid unfavorable outcomes.Conclusions While VP holders could initially be allowed more freedom, the lack of full vaccine effectiveness and increased transmissibility will require accelerated (re-)vaccination, wide-spread immunity surveillance, and/or minimal long-term common restrictions.Plain language summary Assessing the impact of vaccines, other public health measures, and declining immunity on SARS-CoV-2 control is challenging. This is particularly true in the context of vaccination passes, whereby vaccinated individuals have more freedom of making contacts than unvaccinated ones. Here, we use a mathematical model to simulate various scenarios and investigate the likelihood of containing COVID-19 outbreaks in example European countries. We demonstrate that both Alpha and Delta SARS-CoV-2 variants inevitably lead to recurring outbreaks when measures are lifted for vaccination pass holders. High revaccination rates and a lowered fraction of the unvaccinated population increase the benefit of vaccination passes. These observations are important for policy making, highlighting the need for continued vigilance, even where the epidemic is under control, especially when new variants of concern emerge..

Medienart:

Preprint

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

bioRxiv.org - (2022) vom: 25. Mai Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Beteiligte Personen:

Krueger, Tyll [VerfasserIn]
Gogolewski, Krzysztof [VerfasserIn]
Bodych, Marcin [VerfasserIn]
Gambin, Anna [VerfasserIn]
Giordano, Giulia [VerfasserIn]
Cuschieri, Sarah [VerfasserIn]
Czypionka, Thomas [VerfasserIn]
Perc, Matjaz [VerfasserIn]
Petelos, Elena [VerfasserIn]
Rosińska, Magdalena [VerfasserIn]
Szczurek, Ewa [VerfasserIn]

Links:

Volltext [lizenzpflichtig]
Volltext [kostenfrei]

doi:

10.1101/2021.05.07.21256847

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

XBI020563914